Alegeus, the market leader in consumer funding technology, today announced it has named Jacqueline Kosecoff to its Board of Directors, effective immediately. Kosecoff’s appointment reinforces the Alegeus market leadership position and ongoing commitment to enhancing its platform and value proposition.
Kosecoff joins the board as the company gears up for its next phase of growth — establishing itself as the number-one white-label technology provider in the consumer funding space, delivering a best-in-industry HSA experience, and scaling its operations for the rapid growth of its client base, which serves millions of consumers and processes billions of dollars of consumer healthcare payments annually.
Dr. Kosecoff is a seasoned corporate executive and board member with special depth of knowledge in health services and technology. She helped found and lead private equity-backed companies, including Value Health Sciences and Protocare. She went on to serve as Executive Vice President of PacifiCare and CEO of OptumRx at UnitedHealth Group.
Currently, Dr. Kosecoff is working in private equity to identify, select, mentor and manage health companies. She also sits on the board of directors of public companies, including Alignment Healthcare, GoodRx, Houlihan Lokey, STERIS plc and TriNet Group.